Discussions will be in English.
This activity is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners- Accreditation Department (QCHP-AD) and is approved for a maximum of 5.75 hours.
Physicians, trainee physicians, and medical students are invited to attend the ‘Genomics in Clinical Practice’ seminar, which will focus on genomics and genome sequencing technologies.
This Symposium aims to address the following educational objectives:
- Discover the science behind genomics, DNA sequencing, and the implications for patient care
- Increase awareness among medical practitioners of the available technologies, facilities, and resources in genomics in Qatar
- Ensure that physicians and future members of health care teams have the skills to integrate genomic information in practice
- Explore how the fundamentals of genomics are being used for understanding the pathophysiology of the disease.
Overall Learning Objectives:
At the end of the symposium, participants will be able to:
- Define the basic science behind genomics, DNA sequencing, and the implications for patient care.
- Identify the available technologies, facilities and resources in Genomics in Doha.
- Determine the use of genomic information and genetic testing in clinical practice.
- Recognize how the genomics are being used for understanding the pathophysiology of complex diseases such as diabetes and cardiovascular diseases.
Program Overview
Time | Speakers and Talks | Session Learning Outcomes | |
---|---|---|---|
Time:
8:30 am – 9:00 am |
Registration/Coffee |
||
Time:
9:00 am – 9:10 am |
Welcome and Introduction Dr. Edward Stuenkel Dean, College of Health and Life Sciences |
||
Time:
9:10 am – 12:30 am |
Speakers and Talks:
GENOMICS: TECHNOLOGIES AND PLATFORMS Moderator (Dr. Nady El Hajj) Assistant Professor, College of Health and Life Sciences, HBKU |
Session Learning Outcomes: Learning Outcomes |
|
Time:
9:20 am –10:00 am |
Speakers and Talks:
Dr. Ihab Younis Assistant Teaching Professor Carnegie Mellon University in Qatar
Talk Title Introducing basic genomics |
Session Learning Outcomes:
|
|
Time:
10:00 – 10:15 |
Discussion - Q & A | ||
Time:
10:15 am – 10:45 am |
Speakers and Talks:
Dr. Chidambaram Manickam Staff Scientist, Integrated Genomics Services Sidra Medicine
Talk Title Genomic technologies in Qatar |
Session Learning Outcomes:
|
|
Time:
10:45 - 11:00 |
Discussion - Q & A |
||
Time:
11:00 am – 11:40 am |
Speakers and Talks:
Dr. Tawfeg Ben-Omran Head, Clinical and Metabolic Genetics, Hamad Medical Corporation Associate Professor, Weill Cornell Medical College
Talk Title Exome sequencing in clinical practice |
Session Learning Outcomes:
|
|
Time:
11:40 - 12:00 |
Discussion - Q & A |
||
Time:
12:00 pm – 1:30 pm |
Lunch break |
||
Time:
1:30 pm – 5:00 pm |
Speakers and Talks:
CLINICAL APPLICATIONS OF GENOMICS Moderator: Dr. Omar Albagha Principal Investigator, Qatar Biomedical Research Institute, HBKU |
||
Time:
1:30 pm – 2:10 pm |
Speakers and Talks:
Dr. Said Ismail Manager, Qatar Genome Programme
Talk Title What is Qatar Genome Programme?” |
Session Learning Outcomes:
|
|
Time:
2:10 – 2:25 |
Discussion - Q & A |
||
Time:
2:25 pm – 3:05 pm |
Speakers and Talks:
Dr. Donald Love Head, Division of Pathology Genetics Sidra Medicine
Talk Title Diagnostic Genetics: seeing through a glass, darkly |
Session Learning Outcomes:
|
|
Time:
3:05 pm - 03:20 pm |
Discussion - Q & A |
||
Time:
3:20 pm – 3:40 pm |
Coffee Break |
||
Time:
3:40 pm – 4:40 pm 1 CME point |
Speakers and Talks:
Keynote lecture: Dr. André Uitterlinden Professor, Department of Internal Medicine, Genetic Laboratory, Erasmus University, Rotterdam (Netherland)
Talk Title Genomics for complex disorders |
Session Learning Outcomes:
|
|
Time:
4:40 pm – 4:55 pm |
Discussion - Q & A |
||
Time:
4:55 pm – 5:00 pm |
Conclusion and remarks |
||
Time:
5:00 pm – 5:30 pm |
Networking reception |
“The Scientific Planning Committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators, and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.”